Leerink Swann Lowers Alere to Market Perform (ALR)

By admin | 6 years ago

Alere (NYSE: ALR) was downgraded by equities researchers at Leerink Swann from an “outperform” rating to a “market perform” rating in a report issued on Friday.

Alere opened at 19.02 on Friday. Alere has a 52-week low of $17.82 and a 52-week high of $41.18. The company’s market cap is $1.526 billion.

Alere last posted its quarterly earnings results on Monday, April 30th. The company reported $0.77 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.67 by $0.10. Alere’s revenue was up 15.4% compared to the same quarter last year. Analysts expect that Alere will post $0.61 EPS next quarter.

A number of other analysts have also recently weighed in on ALR. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Alere in a research note to investors on Friday.

Alere Inc., formerly Inverness Medical Innovations, Inc., provides diagnostics and health management solutions.

About the author